Poxel - Pharmaceutical Company set-up to find innovative solutions for metabolic diseases management with a primary focus on type 2 diabetes

Our vision

Poxel's vision is to maximize the potential of our pipeline of innovative, first-in-class molecules.

Realizing this vision means successfully developing new, safe and effective treatment options for patients suffering from Type 2 diabetes and other metabolic disorders. We aim in parallel to create substantial added value for our investors. We expect to achieve these aims by exploiting our development expertise and fully leveraging the benefits of our technology.

Sitemap | Legal
© Poxel SA